{"organizations": [], "uuid": "70476536fb861d6b270f8ff980da64f494ecf5fa", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-strongbridge-biopharma-receives-no/brief-strongbridge-biopharma-receives-notice-of-allowance-from-u-s-patent-and-trademark-office-for-new-patent-covering-recorlev-idUSFWN1PD0OA", "country": "US", "domain_rank": 408, "title": "BRIEF-Strongbridge Biopharma Receives Notice Of Allowance From U.S. Patent And Trademark Office For New Patent Covering RECORLEV", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-18T14:39:00.000+02:00", "replies_count": 0, "uuid": "70476536fb861d6b270f8ff980da64f494ecf5fa"}, "author": "", "url": "https://www.reuters.com/article/brief-strongbridge-biopharma-receives-no/brief-strongbridge-biopharma-receives-notice-of-allowance-from-u-s-patent-and-trademark-office-for-new-patent-covering-recorlev-idUSFWN1PD0OA", "ord_in_thread": 0, "title": "BRIEF-Strongbridge Biopharma Receives Notice Of Allowance From U.S. Patent And Trademark Office For New Patent Covering RECORLEV", "locations": [], "entities": {"persons": [{"name": "cushing", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "trademark office for new patent covering recorlev reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "strongbridge biopharma plc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 18, 2018 / 12:40 PM / Updated 32 minutes ago BRIEF-Strongbridge Biopharma Receives Notice Of Allowance From U.S. Patent And Trademark Office For New Patent Covering RECORLEV Reuters Staff 1 Min Read \nJan 18 (Reuters) - Strongbridge Biopharma Plc: \n* STRONGBRIDGE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FROM U.S. PATENT AND TRADEMARK OFFICE FOR NEW PATENT COVERING RECORLEV™ (LEVOKETOCONAZOLE) FOR THE TREATMENT OF CUSHING’S SYNDROME \n* STRONGBRIDGE BIOPHARMA - ‍ TERM OF U.S. PATENT SCHEDULED TO ISSUE FROM APPLICATION WILL EXPIRE JAN 10, 2026, PLUS ANY TIME ALLOWED FOR TERM EXTENSION​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-18T14:39:00.000+02:00", "crawled": "2018-01-18T15:17:01.048+02:00", "highlightTitle": ""}